Vall d'Hebron Institut de Recerca-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion

    Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218